Mettler-Toledo International, Inc. (NYSE:MTD) Receives Consensus Rating of "Hold" from Brokerages

Key Points

• Mettler-Toledo International, Inc. has received an average analyst rating of "Hold", with six analysts rating it as hold and five as buy.
• The average target price set by brokerages for Mettler-Toledo International's stock is $1,298.50, with recent analyst ratings showing varying price targets from $1,110.00 to $1,325.00.
• Recently, insider activity revealed that Director Michael A. Kelly sold 1,062 shares, reducing their ownership significantly by 89.85%.

Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) has been assigned a consensus recommendation of "Hold" from the eleven ratings firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $1,300.00.

A number of equities analysts have recently commented on the company. Barclays assumed coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price objective for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Bank of America boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Finally, Evercore ISI dropped their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday.

Mettler-Toledo International Stock Up 2.8%

NYSE MTD traded up $33.46 during trading on Friday, hitting $1,230.69. 129,244 shares of the stock traded hands, compared to its average volume of 176,654. The company has a market capitalization of $25.57 billion, a P/E ratio of 31.16, a price-to-earnings-growth ratio of 3.64 and a beta of 1.34. The firm has a 50-day simple moving average of $1,193.61 and a 200-day simple moving average of $1,192.54. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter last year, the business posted $9.65 EPS. As a group, research analysts predict that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director directly owned 120 shares in the company, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.77% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its position in Mettler-Toledo International by 39.1% during the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after purchasing an additional 25 shares in the last quarter. QRG Capital Management Inc. boosted its holdings in Mettler-Toledo International by 29.4% in the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after acquiring an additional 111 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock worth $2,929,000 after acquiring an additional 292 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after acquiring an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp boosted its holdings in Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after acquiring an additional 2,296 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.